Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disorder with an estimated
median survival time of 3–5 years after diagnosis. This condition occurs primarily in elderly …

Genes involved in the production of pulmonary surfactant are crucial for the development
and maintenance of healthy lungs. Germline mutations in surfactant-related genes cause a …

Pulmonary alveolar proteinosis (PAP) is a devastating lung disease caused by abnormal
surfactant homeostasis, with a prevalence of 6–7 cases per million population worldwide …

The high prevalence of lung cancer in patients with idiopathic pulmonary fibrosis (3–30%)
has been confirmed by several studies, pointing to specific diagnostic and therapeutic …

Background Autoimmune response after the infection of SARS-COV-2 is evident as more
cases of Guillain Barre syndrome and Kawasaki disease are diagnosed. In this study, we …

Genetic mechanisms are now recognized as rare causes of neonatal lung disease. Genes
potentially responsible for neonatal lung disease include those encoding proteins important …

Pulmonary growth abnormality (PGA) is a common type of diffuse lung disease in infants.
Although the histologic and radiographic features of PGA have been described in the …

A bstract The hereditary form of pulmonary alveolar proteinosis (PAP) is an uncommon
entity. We report a case of PAP due to colony-stimulating factor 2 receptor alpha (CSF2RA) …

Introducción: En recién nacidos con falla respiratoria y enfermedad pulmonar intersticial se
debe realizar el abor daje del Síndrome chILD (children's Interstitial Lung Disease) …

Die idiopathische Lungenfibrose (IPF) ist eine chronische progrediente Erkrankung mit einer
geschätzten medianen Überlebensdauer von 3 bis 5 Jahren ab der Diagnose. Sie tritt …